Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study

Jochen Seufert1 Division of Endocrinology and Diabetology, Department of Internal Medicine II, University Hospital of Freiburg, Freiburg, GermanyCorrespondence[email protected]

Katrin Pegelow2 Sanofi Aventis Deutschland GmbH, Berlin, Germany

Peter Bramlage3 Institut für Pharmakologie und Präventive Medizin, Mahlow, Germany

Pages 711-717 | Published online: 13 Nov 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

EspositoKCozzolinoDBellastellaGDipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trialsDiabetes Obes Metab201113759460321320267
PubMed Web of Science ®Google Scholar
DeaconCFMannucciEAhrenBGlycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes – a review and meta analysisDiabetes Obes Metab201214876276722471248
PubMed Web of Science ®Google Scholar
HollanderPRaslovaKSkjothTVRastamJLiutkusJFEfficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trialDiabetes Obes Metab201113326827521205123
PubMed Web of Science ®Google Scholar
RosenstockJRendellMSGrossJLFleckPRWilsonCAMekkiQAlogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1C) without causing weight gain or increased hypoglycaemiaDiabetes Obes Metab200911121145115219758359
PubMed Web of Science ®Google Scholar
VilsbollTRosenstockJYki-JarvinenHEfficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetesDiabetes Obes Metab201012216717720092585
PubMed Web of Science ®Google Scholar
ArnoldsSDellwegSClairJFurther improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept studyDiabetes Care20103371509151520357372
PubMed Web of Science ®Google Scholar
LigthelmRJBorziVGumprechtJKawamoriRWenyingYValensiPImportance of observational studies in clinical practiceClin Ther2007296 Pt 112841292
Google Scholar
BaxterMAThe role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetesActa Diabetol200845425326818766296
PubMed Web of Science ®Google Scholar
OwensDRBolliGBBeyond the era of NPH insulin – long-acting insulin analogs: chemistry, comparative pharmacology, and clinical applicationDiabetes Technol Ther200810533334918715209
PubMed Web of Science ®Google Scholar
MullinsPSharplinPYki-JarvinenHRiddleMCHaringHUNegative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitusClin Ther20072981607161917919543
PubMed Web of Science ®Google Scholar
GlaserBCerasiEEarly intensive insulin treatment for induction of long-term glycaemic control in type 2 diabetesDiabetes Obes Metab199912677411220514
PubMed Web of Science ®Google Scholar
ORIGIN trial investigatorsGersteinHCBoschJBasal insulin and cardiovascular and other outcomes in dysglycemiaN Engl J Med2012367431932822686416
PubMed Web of Science ®Google Scholar
HolmanRRPaulSKBethelMAMatthewsDRNeilHA10-year follow-up of intensive glucose control in type 2 diabetesN Engl J Med2008359151577158918784090
PubMed Web of Science ®Google Scholar
UK Prospective Diabetes Study (UKPDS) GroupIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet199835291318378539742976
PubMed Web of Science ®Google Scholar
ControlGTurnbullFMAbrairaCIntensive glucose control and macrovascular outcomes in type 2 diabetesDiabetologia200952112288229819655124
PubMed Web of Science ®Google Scholar
RayKKSeshasaiSRWijesuriyaSEffect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trialsLancet200937396771765177219465231
PubMed Web of Science ®Google Scholar
HornePJErjavecMDo infants show generalized imitation of gestures?J Exp Anal Behav2007871638717345952
PubMed Web of Science ®Google Scholar
PennartzCSchenkerNMengeBASchmidtWENauckMAMeierJJChronic reduction of fasting glycemia with insulin glargine improves first- and second-phase insulin secretion in patients with type 2 diabetesDiabetes Care20113492048205321775756
PubMed Web of Science ®Google Scholar
HanefeldMFleischmannHLandgrafWPistroschFEARLY Study: Early Basal Insulin Therapy under Real-Life conditions in type 2 DiabeticsDiabetes, Stoffwechsel und Herz20122129197
Web of Science ®Google Scholar
HanefeldMFleischmannHSchiffhorstGBramlagePPredictors of response to early basal insulin treatment in patients with type-2 diabetes—the EARLY experienceDiab Technol Ther2013
PubMed Web of Science ®Google Scholar
FonsecaVGillJZhouRLeahyJAn analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemiaDiabetes Obes Metab201113981482221481127
PubMed Web of Science ®Google Scholar
MonnierLLapinskiHColetteCContributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)Diabetes Care200326388188512610053
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date